Skip to content

Understanding the importance of adipokines in patients with lymphoma (blood cancer) in the clinical setup

An Observational study to assess the clinical significance of Adipokines in patients with Non-Hodgkin�s Lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030799
Enrollment
31
Registered
2021-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C858- Other specified types of non-Hodgkin lymphoma

Interventions

None listed

Sponsors

JAMIA HAMDARD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who are 18-65 years old 2. Patients who were diagnosed with B -cell NHL either by pathology or cytology (only newly diagnosed) 3. Both genders. 4. Patient capable of giving informed consent 5. Patient willing to participate in the study 6. Patients having Body Mass Index (BMI) less than 30 7. Patient capable of understanding either Hindi or English 7. Patient capable of understanding either Hindi or English

Exclusion criteria

Exclusion criteria: ââ?¬Â¢ Exclusion Criteria: - 1. Patients having a history of cognitive impairment and Alzheimerââ?¬•s disease. 2. Patients having a history of head injury, organ failure and organ transplant 3. Patients having any secondary cancer 4. Patients having neuropsychiatric disorders, neurological and neurobehavioral diseases 5. Patients on any psychotropic medications 6. Patients having a history of drug and alcohol abuse 7. Patients using any concurrent medication like cholinergic drugs, antidepressants, anti-inflammatory drugs or analgesics 8. Lactating or pregnant patients 9. Patients not taking adequate contraception

Design outcomes

Primary

MeasureTime frame
To assess the role of adipokines in physiological processes in B cell Non-Hodgkin�s Lymphoma patientsTimepoint: One time point at baseline before first cycle of chemotherapy

Secondary

MeasureTime frame
To compare the demographic characteristics of Non-Hodgkins Lymphoma patients with healthy human volunteers 2.To compare the neurobehaviour and quality of life of NHL patients with healthy human volunteersTimepoint: One time point study-At baseline

Countries

India

Contacts

Public ContactAfsha Majid

Rajiv Gandhi Cancer Institute and Research Centre

bhurani125@gmail.com9971500861

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026